Immunonutrition with Omega-3 Fatty Acid Supplementation in Severe TBI: Retrospective Analysis of Patient Characteristics and Outcomes.

IF 1.8 Q3 CLINICAL NEUROLOGY
Neurotrauma reports Pub Date : 2024-06-19 eCollection Date: 2024-01-01 DOI:10.1089/neur.2024.0005
Roy A Poblete, Jesus Pena, Grace Kuo, Fawaz Tarzi, Peggy L Nguyen, Steven Y Cen, Shelby Yaceczko, Stan G Louie, Meghan R Lewis, Matthew Martin, Arun P Amar, Nerses Sanossian, Gene Sung, Patrick D Lyden
{"title":"Immunonutrition with Omega-3 Fatty Acid Supplementation in Severe TBI: Retrospective Analysis of Patient Characteristics and Outcomes.","authors":"Roy A Poblete, Jesus Pena, Grace Kuo, Fawaz Tarzi, Peggy L Nguyen, Steven Y Cen, Shelby Yaceczko, Stan G Louie, Meghan R Lewis, Matthew Martin, Arun P Amar, Nerses Sanossian, Gene Sung, Patrick D Lyden","doi":"10.1089/neur.2024.0005","DOIUrl":null,"url":null,"abstract":"<p><p>Early evidence-based medical interventions to improve patient outcomes after traumatic brain injury (TBI) are lacking. In patients admitted to the ICU after TBI, optimization of nutrition is an emerging field of interest. Specialized enteral nutrition (EN) formulas that include immunonutrition containing omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been developed and are used for their proposed anti-inflammatory and proimmune properties; however, their use has not been rigorously studied in human TBI populations. A single-center, retrospective, descriptive observational study was conducted at the LAC + USC Medical Center. Patients with severe TBI (sTBI, Glasgow Coma Scale score ≤ 8) who remained in the ICU for ≥2 weeks and received EN were identified between 2017 and 2022 using the institutional trauma registry. Those who received immunonutrition formulas containing n-3 PUFAs were compared with those who received standard, polymeric EN with regard to baseline characteristics, clinical markers of inflammation and immune function, and short-term clinical outcomes. A total of 151 patients with sTBI were analyzed. Those who received immunonutrition with n-3 PUFA supplementation were more likely to be male, younger, Hispanic/Latinx, and have polytrauma needing non-central nervous system surgery. No differences in clinical markers of inflammation or infection rate were found. In multivariate regression analysis, immunonutrition was associated with reduced hospital length of stay (LOS). ICU LOS was also reduced in the subgroup of patients with polytrauma and TBI. This study identifies important differences in patient characteristics and outcomes associated with the EN formula prescribed. Study results can directly inform a prospective pragmatic study of immunonutrition with n-3 PUFA supplementation aimed to confirm the biomechanistic and clinical benefits of the intervention.</p>","PeriodicalId":74300,"journal":{"name":"Neurotrauma reports","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11257118/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurotrauma reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/neur.2024.0005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Early evidence-based medical interventions to improve patient outcomes after traumatic brain injury (TBI) are lacking. In patients admitted to the ICU after TBI, optimization of nutrition is an emerging field of interest. Specialized enteral nutrition (EN) formulas that include immunonutrition containing omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been developed and are used for their proposed anti-inflammatory and proimmune properties; however, their use has not been rigorously studied in human TBI populations. A single-center, retrospective, descriptive observational study was conducted at the LAC + USC Medical Center. Patients with severe TBI (sTBI, Glasgow Coma Scale score ≤ 8) who remained in the ICU for ≥2 weeks and received EN were identified between 2017 and 2022 using the institutional trauma registry. Those who received immunonutrition formulas containing n-3 PUFAs were compared with those who received standard, polymeric EN with regard to baseline characteristics, clinical markers of inflammation and immune function, and short-term clinical outcomes. A total of 151 patients with sTBI were analyzed. Those who received immunonutrition with n-3 PUFA supplementation were more likely to be male, younger, Hispanic/Latinx, and have polytrauma needing non-central nervous system surgery. No differences in clinical markers of inflammation or infection rate were found. In multivariate regression analysis, immunonutrition was associated with reduced hospital length of stay (LOS). ICU LOS was also reduced in the subgroup of patients with polytrauma and TBI. This study identifies important differences in patient characteristics and outcomes associated with the EN formula prescribed. Study results can directly inform a prospective pragmatic study of immunonutrition with n-3 PUFA supplementation aimed to confirm the biomechanistic and clinical benefits of the intervention.

严重创伤性脑损伤患者补充 Omega-3 脂肪酸的免疫营养:对患者特征和结果的回顾性分析
目前还缺乏早期循证医学干预措施来改善创伤性脑损伤(TBI)后患者的预后。对于创伤性脑损伤后入住重症监护室的患者,优化营养是一个新兴的关注领域。专门的肠内营养(EN)配方包括含有欧米伽-3 多不饱和脂肪酸(n-3 PUFAs)的免疫营养素,并因其抗炎和促进免疫的特性而得到应用。LAC + 南加州大学医学中心开展了一项单中心、回顾性、描述性观察研究。在2017年至2022年期间,通过机构创伤登记册确定了在重症监护室停留≥2周并接受了EN治疗的严重创伤性脑损伤(sTBI,格拉斯哥昏迷量表评分≤8分)患者。在基线特征、炎症和免疫功能的临床指标以及短期临床结果方面,对接受含有 n-3 PUFAs 的免疫营养配方的患者与接受标准聚合EN的患者进行了比较。共对 151 名 sTBI 患者进行了分析。接受 n-3 PUFA 免疫营养补充剂治疗的患者更可能是男性、年轻、西班牙裔/拉丁裔,以及需要进行非中枢神经系统手术的多发性创伤患者。在炎症临床指标或感染率方面没有发现差异。在多变量回归分析中,免疫营养与住院时间(LOS)的缩短有关。在有多发性创伤和创伤性脑损伤的亚组患者中,重症监护室的住院时间也有所缩短。这项研究确定了与免疫营养配方有关的患者特征和预后方面的重要差异。研究结果可直接为补充 n-3 PUFA 的免疫营养前瞻性实用研究提供参考,该研究旨在确认干预措施的生物力学和临床益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
0.00%
发文量
0
审稿时长
8 weeks
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信